Table 1.

Clinical and Laboratory Features of Patients

Patients DiagnosisAutoantibodies (titer) LA ACA
No. Age/Sex GPL MPL Cofactor
1  88/F Stroke  No  No  67  <15  Human β2GPI 
2  28/F  Thrombocytopenia  No  No  85  <15 Bovine β2GPI  
  Migraine  
3  59/F Two fetal losses  ANA (1:100)  No  100  <15 Bovine β2GPI  
4  66/F  Thrombocytopenia ANA (1:100)  No  126  25  LBP  
  Elevated liver enzymes  APCA (1:20)  
5  34/F  Seizures (hysteria?) No  No  54  <15  C4BP  
6  73/F  Polymyalgia rheumatica  APCA (1:20)  No  140  <15  Modified AT 
Patients DiagnosisAutoantibodies (titer) LA ACA
No. Age/Sex GPL MPL Cofactor
1  88/F Stroke  No  No  67  <15  Human β2GPI 
2  28/F  Thrombocytopenia  No  No  85  <15 Bovine β2GPI  
  Migraine  
3  59/F Two fetal losses  ANA (1:100)  No  100  <15 Bovine β2GPI  
4  66/F  Thrombocytopenia ANA (1:100)  No  126  25  LBP  
  Elevated liver enzymes  APCA (1:20)  
5  34/F  Seizures (hysteria?) No  No  54  <15  C4BP  
6  73/F  Polymyalgia rheumatica  APCA (1:20)  No  140  <15  Modified AT 

Abbreviations: ANA, antinuclear antibodies; APCA, antiparietal cell antibodies.

or Create an Account

Close Modal
Close Modal